Bispecific monoclonal antibody therapy (anti HER-2/neu × anti CD 64) for human breast cancers that overexpress HER-2/neu
Year: 1993
Type: article
Study design: Clinical Trial
Source: Journal of Cellular Biochemistry
Institution: Dartmouth–Hitchcock Medical Center
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1964258353
